Dr Simon Day,
Statistics Unit Manager and Scientific Advice Co-ordinator, Medicines and Healthcare products Regulatory Agency
Review of Seroxat and other SSRIs
Over the last 18 months the Committee on Safety of Medicines has been reviewing the safety of SSRIs - a class of antidepressant medicines. This talk will describe some of the review process and some of the data. I will make occasional diversions into UK and EU medicines legislation and comment on some of the media coverage of the issues, the companies involved and the regulatory processes.
Room F3 at Napier University
Comely BAnk Campus (near Western general Hospital)
http://www.napier.ac.uk/campusmaps/comely003.asp
Monday 24th January 2005, 4 to 5pm
|